Theillet C - Search Results

1

A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer.

Chanrion M, Negre V, Fontaine H, Salvetat N, Bibeau F, Mac Grogan G, Mauriac L, Katsaros D, Molina F, Theillet C, Darbon JM. Chanrion M, et al. Among authors: theillet c. Clin Cancer Res. 2008 Mar 15;14(6):1744-52. doi: 10.1158/1078-0432.CCR-07-1833. Clin Cancer Res. 2008. PMID: 18347175 Free PMC article.

2

p53 mutations occur in aggressive breast cancer.

Mazars R, Spinardi L, BenCheikh M, Simony-Lafontaine J, Jeanteur P, Theillet C. Mazars R, et al. Among authors: theillet c. Cancer Res. 1992 Jul 15;52(14):3918-23. Cancer Res. 1992. PMID: 1617667

3

FGFRI and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers.

Theillet C, Adelaide J, Louason G, Bonnet-Dorion F, Jacquemier J, Adnane J, Longy M, Katsaros D, Sismondi P, Gaudray P, et al. Theillet C, et al. Genes Chromosomes Cancer. 1993 Aug;7(4):219-26. doi: 10.1002/gcc.2870070407. Genes Chromosomes Cancer. 1993. PMID: 7692948

4

Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors.

Courjal F, Louason G, Speiser P, Katsaros D, Zeillinger R, Theillet C. Courjal F, et al. Among authors: theillet c. Int J Cancer. 1996 Aug 22;69(4):247-53. doi: 10.1002/(SICI)1097-0215(19960822)69:4<247::AID-IJC1>3.0.CO;2-X. Int J Cancer. 1996. PMID: 8797862

5

DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours.

Courjal F, Cuny M, Rodriguez C, Louason G, Speiser P, Katsaros D, Tanner MM, Zeillinger R, Theillet C. Courjal F, et al. Among authors: theillet c. Br J Cancer. 1996 Dec;74(12):1984-9. doi: 10.1038/bjc.1996.664. Br J Cancer. 1996. PMID: 8980401 Free PMC article.

6

Loss of heterozygosity on the long arm of chromosome 6 in breast cancer: possibly four regions of deletion.

Noviello C, Courjal F, Theillet C. Noviello C, et al. Among authors: theillet c. Clin Cancer Res. 1996 Sep;2(9):1601-6. Clin Cancer Res. 1996. PMID: 9816339

7

In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity.

Bautista S, Vallès H, Walker RL, Anzick S, Zeillinger R, Meltzer P, Theillet C. Bautista S, et al. Among authors: theillet c. Clin Cancer Res. 1998 Dec;4(12):2925-9. Clin Cancer Res. 1998. PMID: 9865902

8

Relating genotype and phenotype in breast cancer: an analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations.

Cuny M, Kramar A, Courjal F, Johannsdottir V, Iacopetta B, Fontaine H, Grenier J, Culine S, Theillet C. Cuny M, et al. Among authors: theillet c. Cancer Res. 2000 Feb 15;60(4):1077-83. Cancer Res. 2000. PMID: 10706127

9

Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation.

Vendrell JA, Magnino F, Danis E, Duchesne MJ, Pinloche S, Pons M, Birnbaum D, Nguyen C, Theillet C, Cohen PA. Vendrell JA, et al. Among authors: theillet c. J Mol Endocrinol. 2004 Apr;32(2):397-414. doi: 10.1677/jme.0.0320397. J Mol Endocrinol. 2004. PMID: 15072547

10

Amplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcome.

Rodriguez C, Hughes-Davies L, Vallès H, Orsetti B, Cuny M, Ursule L, Kouzarides T, Theillet C. Rodriguez C, et al. Among authors: theillet c. Clin Cancer Res. 2004 Sep 1;10(17):5785-91. doi: 10.1158/1078-0432.CCR-03-0410. Clin Cancer Res. 2004. PMID: 15355907

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters